Journey Medical (DERM) Accounts Payables (2020 - 2026)

Journey Medical has reported Accounts Payables for 7 years, with the latest figure at $8.2 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables fell 43.06% year-over-year to $8.2 million; the trailing twelve-month figure through Mar 2026 stood at $8.2 million (down 43.06% YoY), and the FY2025 full-year result was $8.9 million, down 44.85% from the prior year.
• Accounts Payables for Q1 2026 stood at $8.2 million, down from $8.9 million in the prior quarter.
• The five-year high for Accounts Payables was $43.7 million in Q1 2023, with the low at $8.2 million in Q1 2026.
• Historically, Accounts Payables has averaged $21.7 million across 5 years, with a median of $16.0 million in 2024.
• Annual changes were most pronounced in 2022 — Accounts Payables jumped 5504.33% — and 2024, when it slumped 64.86%.
• Journey Medical's Accounts Payables stood at $36.6 million in 2022, then sank by 50.37% to $18.1 million in 2023, then decreased by 11.57% to $16.0 million in 2024, then sank by 44.85% to $8.9 million in 2025, then dropped by 7.33% to $8.2 million in 2026.
• The last three Accounts Payables figures came in at $8.2 million (Q1 2026), $8.9 million (Q4 2025), and $11.6 million (Q3 2025), per Business Quant data.